AI Verdict
IMCR has stronger fundamentals based on our AI analysis.
IMMX vs IMCR Fundamental Comparison
| Metric | IMMX | IMCR |
|---|---|---|
| Revenue | $20.0M | $400.0M |
| Net Income | $-29.4M | $-35.5M |
| Net Margin | -147.2% | -8.9% |
| ROE | -31.4% | -9.3% |
| ROA | -28.1% | -3.3% |
| Current Ratio | 10.01x | 4.04x |
| Debt/Equity | 0.00x | 1.15x |
| EPS | $-0.89 | $-0.71 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
IMMX vs IMCR: Frequently Asked Questions
Is IMMX or IMCR a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), IMCR has stronger fundamentals. IMMX is rated SELL (75% confidence) while IMCR is rated HOLD (65% confidence). This is not investment advice.
How does IMMX compare to IMCR fundamentally?
Immix Biopharma, Inc. has ROE of -31.4% vs Immunocore Holdings plc's -9.3%. Net margins are -147.2% vs -8.9% respectively.
Which stock pays higher dividends, IMMX or IMCR?
IMMX has a dividend yield of N/A or no dividend while IMCR has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in IMMX or IMCR for long term?
For long-term investing, consider that IMMX has SELL rating with 75% confidence, while IMCR has HOLD rating with 65% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about IMMX vs IMCR?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For IMMX vs IMCR, the AI consensus favors IMCR based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.